Neimeth International Pharmaceuticals Financial Health

Short Term Liabilities: NEIMETH's short term assets (NGN3.7B) exceed its short term liabilities (NGN3.6B).

Long Term Liabilities: NEIMETH's short term assets (NGN3.7B) exceed its long term liabilities (NGN2.1B).

Debt Level: NEIMETH's net debt to equity ratio (427.4%) is considered high.

Reducing Debt: NEIMETH's debt to equity ratio has increased from 119.2% to 477.4% over the past 5 years.

Debt Coverage: NEIMETH's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if NEIMETH's interest payments on its debt are well covered by EBIT.

• Healthy companies in the Pharmaceuticals & Biotech industry.